Activation of lymphocytes by brominated nucleoside and cyclic nucleotide analogues: implications for the "second messenger" function of cyclic GMP.
AUTOR(ES)
Goodman, M G
RESUMO
The purine nucleoside guanosine, when derivatized at the C-8 position to give 8-bromoguanosine (8-BrGuo), acquires the capacity to stimulate high-level lymphocyte proliferation in the presence or absence of serum. Direct comparisons were undertaken to determine whether this activity is exerted only by virtue of the structural resemblance of 8-BrGuo to 8-bromo cyclic GMP (8-BrcGMP) (a known intracellular lymphocyte mitogen). They showed that, of the brominated guanosine derivatives studied, 8-BrGuo is the primary activator because (i) it is a far more potent lymphocyte activator than 8-BrcGMP, the order of mitogenic potency being 8-BrGuo greater than 8-bromo GMP (8-BrGMP) greater than 8-BrcGMP; (ii) it acts much more rapidly than 8-BrcGMP; (iii) it is not metabolized to 8-BrcGMP or cGMP; and (iv) it does not elevate intracellular cGMP content. cGMP is not likely to be the second messenger serving to activate B cells because (i) it does not induce significant proliferation unless brominated at the C-8 position; (ii) the brominated form is much less efficient than 8-BrGuo or 8-BrGMP; (iii) 8-BrGuo and many other mitogens do not increase intracellular cGMP; (iv) many agents that increase cGMP fail to initiate lymphocyte activation; (v) certain agents that increase cGMP (i.e., 15-hydroperoxyarachidonic acid, azide) inhibit lymphocyte activation; and (vi) addition of unbrominated cGMP to cultures stimulated with 8-BrGuo actually diminished stimulation. These data (i) indicate that, by interaction with cellular components, 8-BrGuo triggers high level lymphocyte activation and (ii) cast significant doubt on the role of cGMP as an intracellular second messenger in lymphocyte proliferation.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=349317Documentos Relacionados
- Inhibition of growth of Rhizobium japonicum by cyclic GMP.
- Modification of human DNA-dependent RNA polymerase activity by cyclic GMP.
- Inhibition and stimulation of the development of the bioluminescent system in Beneckea harveyi by cyclic GMP.
- Osteoclastic inhibition: an action of nitric oxide not mediated by cyclic GMP.
- Dual activation of a sex pheromone-dependent ion channel from insect olfactory dendrites by protein kinase C activators and cyclic GMP.